Welcome to Reddy US Therapeutics, Inc.

Reddy US Therapeutics, Inc. was established in November 1999. We are a subsidiary of Dr. Reddy's Laboratories Limited, Hyderabad, India. Dr. Reddy's Laboratories Limited is a fully integrated pharmaceutical company with a presence in over 100 countries around the globe.

As part of Dr. Reddy's Discovery Research division, we are dedicated to discovering novel therapeutics that address unmet medical needs in metabolic and cardiovascular diseases.

Our discovery efforts focus on identifying treatment gaps in current therapeutics and developing mechanism based multi-prong approach to treat the disease. Using our technology platform, we have identified novel therapeutic targets with potential applications in metabolic and cardiovascular diseases. Through directed medicinal chemistry efforts, we have discovered small molecules that modulate these targets and show excellent therapeutic effects in models of dyslipidemia and atherosclerosis. In addition to utility in metabolic diseases, our technology platform has potential to modulate diseases such as Alzheimer's and Glaucoma.